234 related articles for article (PubMed ID: 22009305)
1. Characterization and optimization of orodispersible mosapride film formulations.
ElMeshad AN; El Hagrasy AS
AAPS PharmSciTech; 2011 Dec; 12(4):1384-92. PubMed ID: 22009305
[TBL] [Abstract][Full Text] [Related]
2. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
Limpongsa E; Umprayn K
AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
[TBL] [Abstract][Full Text] [Related]
4. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.
Al-Oran AYF; Yenilmez E
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
6. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.
Krull SM; Patel HV; Li M; Bilgili E; Davé RN
Eur J Pharm Sci; 2016 Sep; 92():146-55. PubMed ID: 27402100
[TBL] [Abstract][Full Text] [Related]
7. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics.
Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669
[TBL] [Abstract][Full Text] [Related]
8. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
10. Formulation optimization of solid dispersion of mosapride hydrochloride.
Kim HJ; Lee SH; Lim EA; Kim JS
Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
[TBL] [Abstract][Full Text] [Related]
11. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
12. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
13. Fast dissolving films made of maltodextrins.
Cilurzo F; Cupone IE; Minghetti P; Selmin F; Montanari L
Eur J Pharm Biopharm; 2008 Nov; 70(3):895-900. PubMed ID: 18667164
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of orodispersible film containing diltiazem hydrochloride with taste masked effects.
Latif S; Kokab A; Afzal H; Shoaib QA; Hameed M; Manzoor M; Batool N; Ijaz QA
Pak J Pharm Sci; 2022 Jul; 35(4):1007-1014. PubMed ID: 36008896
[TBL] [Abstract][Full Text] [Related]
15. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
El-Bary AA; Al Sharabi I; Haza'a BS
Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of orally disintegrating tablets containing the mosapride resin complex.
Wu T; Wang G; Shi C; Li J; Zhao N; Dong Z; Pan W; Zhang X
Acta Pharm; 2018 Jun; 68(2):159-170. PubMed ID: 29702482
[TBL] [Abstract][Full Text] [Related]
17. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
18. Preparation of buccal patch composed of carbopol, poloxamer and hydroxypropyl methylcellulose.
Chun MK; Kwak BT; Choi HK
Arch Pharm Res; 2003 Nov; 26(11):973-8. PubMed ID: 14661865
[TBL] [Abstract][Full Text] [Related]
19. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
20. Poly(methyl methacrylate) salt as film forming material to design orodispersible films.
Musazzi UM; Selmin F; Franzé S; Gennari CGM; Rocco P; Minghetti P; Cilurzo F
Eur J Pharm Sci; 2018 Mar; 115():37-42. PubMed ID: 29329745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
